Literature DB >> 33670759

Macrophages in Lung Injury, Repair, and Fibrosis.

Peiyong Cheng1, Shuangyan Li2, Huaiyong Chen1,2,3,4.   

Abstract

Fibrosis progression in the lung commonly results in impaired functional gas exchange, respiratory failure, or even death. In addition to the aberrant activation and differentiation of lung fibroblasts, persistent alveolar injury and incomplete repair are the driving factors of lung fibrotic response. Macrophages are activated and polarized in response to lipopolysaccharide- or bleomycin-induced lung injury. The classically activated macrophage (M1) and alternatively activated macrophage (M2) have been extensively investigated in lung injury, repair, and fibrosis. In the present review, we summarized the current data on monocyte-derived macrophages that are recruited to the lung, as well as alveolar resident macrophages and their polarization, pyroptosis, and phagocytosis in acute lung injury (ALI). Additionally, we described how macrophages interact with lung epithelial cells during lung repair. Finally, we emphasized the role of macrophage polarization in the pulmonary fibrotic response, and elucidated the potential benefits of targeting macrophage in alleviating pulmonary fibrosis.

Entities:  

Keywords:  acute lung injury; lung epithelial cells; lung repair; macrophage; pulmonary fibrosis

Year:  2021        PMID: 33670759     DOI: 10.3390/cells10020436

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  22 in total

Review 1.  Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19.

Authors:  Daniel Clark Files; Frank Tacke; Alexandra O'Sullivan; Patrick Dorr; William G Ferguson; William G Powderly
Journal:  PLoS Pathog       Date:  2022-06-24       Impact factor: 7.464

2.  Ameliorative Effects of Arctigenin on Pulmonary Fibrosis Induced by Bleomycin via the Antioxidant Activity.

Authors:  Yueshang Wang; Xinpeng Li; Shiwen Pu; Xiao Wang; Lanping Guo; Lisheng Zhang; Zhen Wang
Journal:  Oxid Med Cell Longev       Date:  2022-07-05       Impact factor: 7.310

Review 3.  Lung Models to Evaluate Silver Nanoparticles' Toxicity and Their Impact on Human Health.

Authors:  Jesús Gabriel González-Vega; Juan Carlos García-Ramos; Rocio Alejandra Chavez-Santoscoy; Javier Emmanuel Castillo-Quiñones; María Evarista Arellano-Garcia; Yanis Toledano-Magaña
Journal:  Nanomaterials (Basel)       Date:  2022-07-05       Impact factor: 5.719

Review 4.  Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

Authors:  Elena Ortiz-Zapater; Jaime Signes-Costa; Paula Montero; Inés Roger
Journal:  Biomedicines       Date:  2022-06-15

5.  Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2.

Authors:  Wu Luo; Li-Bin Yang; Chen-Chen Qian; Bao Ma; Gloria M Manjengwa; Xiao-Min Miao; Jie Wang; Cheng-Hong Hu; Bo Jin; Ling-Xi Zhang; Chao Zheng; Guang Liang; Yi Wang
Journal:  Acta Pharmacol Sin       Date:  2021-11-04       Impact factor: 7.169

Review 6.  The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.

Authors:  Jae-Won Lee; Wanjoo Chun; Hee Jae Lee; Jae-Hong Min; Seong-Man Kim; Ji-Yun Seo; Kyung-Seop Ahn; Sei-Ryang Oh
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

Review 7.  The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

8.  Caspase-1-mediated extracellular vesicles derived from pyroptotic alveolar macrophages promote inflammation in acute lung injury.

Authors:  Xichun Qin; Yueyuan Zhou; Caili Jia; Zhixiang Chao; Hao Qin; Jingtian Liang; Xiucheng Liu; Zhiwei Liu; Teng Sun; Yanliang Yuan; Hao Zhang
Journal:  Int J Biol Sci       Date:  2022-01-24       Impact factor: 6.580

Review 9.  SARS-CoV-2 Infection and Lung Regeneration.

Authors:  Fuxiaonan Zhao; Qingwen Ma; Qing Yue; Huaiyong Chen
Journal:  Clin Microbiol Rev       Date:  2022-02-02       Impact factor: 50.129

Review 10.  Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation.

Authors:  Anna Salvati; Klaas Poelstra
Journal:  Pharmaceutics       Date:  2022-01-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.